Even if GLP-1 and GIP secretion are present in these scenarios, both hormones usually have decreased effectiveness
Brand-name GLP-1 and GLP-1/GIP medicationsWegovy/Ozempic (semaglutide) and Mounjaro/Zepbound (tirzepatide)are FDA-approved for specific uses and require a medical evaluation
A physician consultation is required before dispensing
Emerging Understanding of Long-term Effects More data from ongoing and finished clinical trials is helping us understand semaglutides long-term effects in post-surgical patients
Encouragingly, there may now be a better solution than any of these three hacks. Novo Nordisks Wegovy pill, an oral form of semaglutide, was FDA-approved in December 2025 and launched in January 2026
Tirzepatide's manufacturing, as described by Eli Lilly's Kinsale team, requires a five-step HPLC purification sequence and generates a complex impurity profile that demands sophisticated analytical characterisation at every stage